Standardization · SIS/TK 340

Biologisk säkerhet för medicintekniska produkter

Kirurgiska implantat används för att ersätta kroppsdelar samt för att förstärka, stötta och stabilisera olika funktioner i kroppen. Biologisk säkerhet innebär att de medicintekniska produkter som kommer i direktkontakt med kroppen ska vara oskadliga för människan.

Kommitténs arbete omfattar standarder för biologisk säkerhet och biokompatibilitet, kirurgiska implantat, kliniska prövningar samt klinisk utvärdering av medicintekniska produkter.

Målet är att ge både patient och personal säkra produkter genom att ta fram standarder med relevanta krav för olika typer av implantat samt provningsmetoder för alla kategorier av medicintekniska produkter som kommer i kontakt med människokroppen.

Standarderna utgör också en central del för att produkterna skall godkännas för marknadsföring i Europa, USA och övriga världen.

Standarderna för biologisk säkerhet beskriver olika typer av provningsmetoder för att bl.a. fastställa att en produkt inte är toxisk, carcinogen, påverkar reproduktionen, ger upphov till allergier eller ger lokala oönskade reaktioner. Detta gäller såväl engångsartiklar som infusionsaggregat och kanyler som mer kvalificerade produkter som kirurgiska implantat, anestesiutrustningar och djurvävnad.

More information about the committèes work:

Verksamhetsplan Verksamhetsplan
Now working on 100 standards
ISO/DTS 25364-1, Chemical characterization of medical devices — Part 1: Identification of organic extractables in non-targeted analysis (NTA) (50.20)
ISO/FDIS 8637-1, Extracorporeal systems for blood purification — Part 1: Haemodialysers, haemodiafilters, haemofilters and haemoconcentrators (50.20)
ISO/FDIS 8637-2, Extracorporeal systems for blood purification — Part 2: Extracorporeal blood and fluid circuits for haemodialysers, haemodiafilters, haemofilters and haemoconcentrators (50.20)
ISO/FDIS 8637-3, Extracorporeal systems for blood purification — Part 3: Plasmafilters (50.20)
ISO/DTS 7020, Sizing parameters of surgical valve prostheses: Requirements regarding the application of ISO 5840-2 (50.00)
ISO/FDIS 10993-16, Biological evaluation of medical devices — Part 16: Toxicokinetic evaluation for degradation products and leachables (50.00)
ISO/FDIS 18969, Clinical evaluation of medical devices - Principles and process for planning and performing clinical evaluation (50.00)
ISO/FDIS 21762, Medical devices utilizing non-viable human materials — Application of risk management (50.00)
ISO/DTS 21726, Biological evaluation of medical devices — Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents (50.00)
ISO/DIS 10993-2, Biological evaluation of medical devices — Part 2: Animal welfare requirements (40.99)
ISO/DIS 20014, Implants for surgery — Test method for the evaluation of delamination resistance of ultra-high molecular weight polyethylene materials used for orthopaedic implants (40.99)
ISO/DIS 16428, Implants for surgery — Test solutions and environmental conditions for static and dynamic corrosion tests on implantable materials and medical devices (40.60)
ISO/DIS 13782, Implants for surgery — Metallic materials — Unalloyed tantalum for surgical implant applications (40.60)
ISO/DIS 10993-4, Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood (40.60)
ISO/DIS 7206-6, Implants for surgery — Partial and total hip joint prostheses — Part 6: Endurance properties testing and performance requirements of neck region of stemmed femoral components (40.60)
ISO/DIS 5832-12, Implants for surgery — Metallic materials — Part 12: Wrought cobalt-chromium-molybdenum alloy (40.60)
ISO/DIS 5832-14, Implants for surgery — Metallic materials — Part 14: Wrought titanium 15-molybdenum 5-zirconium 3-aluminium alloy (40.60)
ISO/DIS 5832-9, Implants for surgery — Metallic materials — Part 9: Wrought high nitrogen stainless steel (40.60)
ISO/DIS 6474-1, Implants for surgery — Ceramic materials: Alumina — Part 1: Monolithic high-purity alumina (40.60)
ISO/DIS 7198, Cardiovascular implants and extracorporeal systems — Vascular prostheses — Tubular vascular grafts and vascular patches (40.60)
IEC/DIS 80601-2-31, Medical electrical equipment — Part 2-31: Particular requirements for the basic safety and essential performance of external cardiac pacemakers with internal power source (40.60)
ISO/DIS 10974, Assessment of the safety of magnetic resonance imaging for patients with an active implantable medical device (40.60)
ISO/DIS 10993-11.2, Biological evaluation of medical devices — Part 11: Tests for systemic toxicity (40.60)
ISO/DIS 13356, Implants for surgery —Alumina ceramic material: Zirconia — Yttria-stabilized tetragonal zirconia (Y-TZP) (40.20)
ISO/DIS 14708-1, Implants for surgery — Active implantable medical devices — Part 1: General requirements for safety, marking and for information to be provided by the manufacturer (40.20)
ISO/DIS 19213, Implants for surgery — Test methods of material for use as a cortical bone model (40.20)
ISO/DIS 19227, Implants for surgery — Cleanliness of orthopedic implants — General requirements (40.20)
ISO/DIS 7206-1, Implants for surgery — Partial and total hip joint prostheses — Part 1: Classification and designation of dimensions (40.00)
ISO/CD 25695, Medical devices utilizing bioengineered biological substances — Application of risk management (30.60)
ISO/CD 25735, Device output-parameters, abbreviations, and units for displaying and storage in extracorporeal life support (30.60)
ISO/CD 8250, Characterization of residuals relevant to the biological evaluation of medical devices (30.60)
ISO/CD TR 24850, Sources of hazard information for medical device constituents (30.60)
ISO/CD TS 17137, Cardiovascular implants and extracorporeal systems — Cardiovascular absorbable implants (30.60)
ISO/CD TS 20324, Generation of medical device extracts for chemical analysis to support toxicological risk assessment (30.60)
ISO/CD TS 25364-2.2, Analytical chemistry matters associated with ISO 10993-18 — Part 2: Quantification of medical device extractables and leachables using Non-Targeted Analysis (NTA) (30.60)
ISO/CD TS 25364-3, Analytical chemistry matters associated with ISO 10993-18 — Part 3: Instrumental and human requirements for evaluating organic medical device extractables and leachables via Non-Targeted Analysis (NTA) (30.60)
ISO/CD TS 26177, Biological evaluation of medical devices – Guidance on risk estimation and evaluation in the application of ISO 10993-1 (30.60)
ISO/CD TS 26420, Biological evaluation of medical devices — Guidance on the impact of bioaccumulation and intermittent contact in the application of ISO 10993-1 (30.60)
ISO/CD 23500-1, Preparation and quality management of fluids for haemodialysis and related therapies — Part 1: General requirements (30.60)
ISO/CD 23500-2, Preparation and quality management of fluids for haemodialysis and related therapies — Part 2: Water treatment equipment for haemodialysis applications and related therapies (30.60)
ISO/CD 23500-3, Preparation and quality management of fluids for haemodialysis and related therapies — Part 3: Water for haemodialysis and related therapies (30.60)
ISO/CD 23500-4, Preparation and quality management of fluids for haemodialysis and related therapies — Part 4: Concentrates for haemodialysis and related therapies (30.60)
ISO/CD 23500-5, Preparation and quality management of fluids for haemodialysis and related therapies — Part 5: Quality of dialysis fluid for haemodialysis and related therapies (30.60)
ISO/CD 14243-1, Implants for surgery — Wear of total knee-joint prostheses — Part 1: Methodology for simulator wear testing of tibio-femoral joints under force control (30.60)
ISO/CD 14243-3, Implants for surgery — Wear of total knee-joint prostheses — Part 3: Methodology for simulator wear testing of tibio-femoral joints under displacement control. (30.60)
ISO/CD 24085-1, Implants for Surgery — Partial and total shoulder joint replacement — Part 1: Determination of resistance to torque of head fixation of modular humeral components (30.20)
ISO/CD 16436-2, Implants for surgery — Wear of total shoulder-joint prostheses — Part 2: Methodology for simulator wear testing of reverse total shoulder-joint prostheses (30.20)
ISO/CD 18993, Implants for surgery — Joint replacement implants — Methods for cleaning, wear measurements, and wear rate determination (30.00)
IEC/AWI TS 63757, Single fault conditions of magnetic resonance equipment and other considerations for magnetic resonance conditional implant assessments (20.00)
ISO/AWI 7614, Tissue-engineered medical products — The method for quantification of residual DNA in decellularized ECM scaffolds (20.00)
ISO/AWI TS 11967, Biological evaluation of medical devices — Guidance on commissioning scientifically robust chemical characterization testing in accordance with ISO 10993-18 (20.00)
ISO/AWI TS 24830, Application of in-silico/read-across approaches for identifying a medical device constituent analogue (20.00)
ISO/AWI TS 25364-4, Analytical chemistry matters associated with ISO 10993-18 — Part 4: Critical aspects of extract viability in extractables and leachables testing using non-targeted analysis (NTA) (20.00)
ISO/AWI 14155, Clinical investigation of medical devices for human subjects — Good clinical practice (20.00)
ISO/AWI 22442-1, Medical devices utilizing tissues and their derivatives — Part 1: Application of risk management (20.00)
ISO/AWI 22442-2, Medical devices utilizing tissues and their derivatives — Part 2: Controls on sourcing, collection and handling (20.00)
ISO/AWI 26302, Ventricular assist devices and total artificial hearts (20.00)
ISO/AWI 5832-1, Implants for surgery — Metallic materials — Part 1: Wrought stainless steel (20.00)
ISO/AWI 22442-3, Medical devices utilizing animal tissues and their derivatives — Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents (10.99)
ISO 5834-1:2025/AWI Cor 1, Implants for surgery — Ultra-high-molecular-weight polyethylene — Part 1: Powder form — Technical Corrigendum 1 (10.99)
ISO 6631:2025/AWI Amd 1, Tissue-engineered medical products — Quantification of bovine type I collagen marker peptide with liquid chromatography — Tandem mass spectrometry — Amendment 1 (10.99)
ISO/AWI 10993-13, Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices (10.99)
ISO/AWI 10993-14, Biological evaluation of medical devices — Part 14: Identification and quantification of degradation products from ceramics (10.99)
ISO/AWI 11318, Cardiac defibrillators — Connector assembly DF-1 for implantable defibrillators — Dimensions and test requirements (10.99)
ISO/AWI 12891-1, Retrieval and analysis of surgical implants — Part 1: Retrieval and handling (10.99)
ISO/AWI 12891-2, Retrieval and analysis of surgical implants — Part 2: Analysis of retrieved surgical implants (10.99)
ISO/AWI 13781, Implants for surgery — Homopolymers, copolymers and blends on poly(lactide) — In vitro degradation testing (10.99)
ISO/AWI 5841-3, Implants for surgery — Cardiac pacemakers — Part 3: Low-profile connectors (IS-1) for implantable pacemakers (10.99)
ISO/AWI 7206-2, Implants for surgery — Partial and total hip joint prostheses — Part 2: Articulating surfaces made of metallic, ceramic and plastics materials (10.99)
EN ISO 16061:2021/prA11, Instruments for use in association with non-active surgical implants - General requirements (ISO 16061:2021) (10.99)
EN ISO 21534:2009/prA11, Non-active surgical implants - Joint replacement implants - Particular requirements (ISO 21534:2007) (10.99)
ISO/NP 25405.3, Tissue-engineered medical products-General requirement of bio-derived scaffold material for peripheral nerve repair (10.60)
ISO/NP 27132, Non-active surgical implants — General requirements for personalized surgical implants (10.20)
ISO/NP TS 27161, Radial expansion resistance characterization of flexible surgical heart valve prostheses (10.20)
ISO/PWI 4403, Implants for surgery — Test method for flexural strength of porous calcium salt bone void filler after preconditioning in deaerated phosphate buffered saline (00.60)
ISO/PWI 25281, Tissue engineered medical products — Characterization and evaluation of recombinant collagen as starting material for TEMPs (00.60)
ISO/PWI 25406, Tissue Engineered Medical Products — Characterization and evaluation of silk fibroin as a starting material for TEMPs (00.60)
ISO/PWI 10993-10, Biological evaluation of medical devices — Part 10: Tests for skin sensitization (00.00)
ISO/PWI 10993-23, Biological evaluation of medical devices — Part 23: Tests for irritation (00.00)
ISO/PWI 10993-5, Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity (00.00)
ISO/PWI 13175-3, Implants for surgery — Calcium phosphates — Part 3: Hydroxyapatite and beta-tricalcium phosphate bone substitutes (00.00)
ISO/PWI 14117.2, Active implantable medical devices — Electromagnetic compatibility — EMC test protocols for implantable cardiac pacemakers, implantable cardioverter defibrillators and cardiac resynchronization devices (00.00)
ISO/PWI 14242-3.2, Implants for surgery — Wear of total hip-joint prostheses — Part 3: Loading and displacement parameters for orbital bearing type wear testing machines and corresponding environmental conditions for test (00.00)
ISO/PWI 14242-4.2, Implants for surgery — Wear of total hip-joint prostheses — Part 4: Testing hip prostheses under variations in component positioning which results in direct edge loading (00.00)
ISO/PWI 14243-5.2, Implants for surgery — Wear of total knee prostheses — Part 5: Durability performance of the patellofemoral joint (00.00)
ISO/PWI 14708-2, Implants for surgery — Active implantable medical devices — Part 2: Cardiac pacemakers (00.00)
ISO/PWI 14708-3, Implants for surgery — Active implantable medical devices — Part 3: Implantable neurostimulators (00.00)
ISO/PWI 14708-6, Implants for surgery — Active implantable medical devices — Part 6: Particular requirements for active implantable medical devices intended to treat tachyarrhythmia (including implantable defibrillators) (00.00)
ISO/PWI 14949.2, Implants for surgery — Two-part addition-cure silicone elastomers (00.00)
ISO/PWI 16054, Implants for surgery — Minimum data sets for surgical implants (00.00)
ISO/PWI 16061, Instruments for use in association with non-active surgical implants — General requirements (00.00)
ISO/PWI 16087.2, Implants for surgery — Roentgen stereophotogrammetric analysis for the assessment of migration of orthopaedic implants (00.00)
ISO/PWI 18368, Implants for surgery — Nitride ceramic materials — Monolithic materials made of beta silicon-nitride (00.00)
ISO/PWI 18531, Implants for surgery — Calcium salt based bioceramics — Characterization of hardening bone paste materials (00.00)
ISO/PWI 22622, Implants for surgery — Wear of total ankle-joint prostheses — Loading and displacement parameters for wear-testing machines with load or displacement control and corresponding environmental conditions for test (00.00)
ISO/PWI 24085-2, Implants for Surgery - Partial and total shoulder joint prosthesis — Part 2: Determination of resistance to torque-off head fixation of modular humeral prostheses (00.00)
ISO/PWI 24964, EMC for leadless pacemakers (00.00)
ISO/PWI 26710, Transcatheter delivery systems for cardiac valves repair and replacement (00.00)
ISO/PWI 27153, Transcatheter delivery systems for cardiac valves repair and replacement (00.00)
ISO/PWI 27169, Implants for surgery - Shelf life and stability evaluation (00.00)
Show more Show less
Published 66 standards
Show more Show less
Working group 3 workgroups
SIS/TK 340/AG 01, Kliniska prövningar
SIS/TK 340/AG 02, Biologisk säkerhet
SIS/TK 340/AG 03, Implantat
Participants 19 companies and organizations
ACR Consulting SL, Madrid
Aurevia, Kista
Essity Hygiene and Health AB, Mölndal
GBA Key2Compliance AB, Nacka Strand
KF Toxicology Consulting AB, Mölnlycke
Lunds Universitet, Lund
Maquet Critical Care AB, Solna
Mediteq Svenkebo AB, Göteborg
MissionTech AB, Lidingö
Mölnlycke Health Care AB, Mölndal
Nipro Nordics AB, Stockholm
Region Skåne, Lund
RISE Research Institutes of Sweden AB, Borås
Scandinavian Real Heart AB, Västerås
SenzaGen AB, Lund
Sveriges Tandläkarförbund, Stockholm
Veranex Sweden AB, Mölndal
Wellspect AB, Mölndal
WL Gore & Associates Scandinavia AB, Mölndal
Show more Show less
International participation 51 international committees
SIS/TK 340/AG 01, Kliniska prövningar:

CEN/TC 206, Biological and clinical evaluation of medical devices

ISO/TC 194/WG 4, Clinical investigation and evaluation of medical devices in humans

SIS/TK 340/AG 02, Biologisk säkerhet:

CEN/TC 206, Biological and clinical evaluation of medical devices

ISO/TC 194, Biological and clinical evaluation of medical devices

ISO/TC 194/SAG, Strategic Advisory Group

ISO/TC 194/WG 1, Systematic approach to biological evaluation and terminology

ISO/TC 194/WG 10, Implantation

ISO/TC 194/WG 11, Allowable limits for leachable substances

ISO/TC 194/WG 12, Sample preparation and reference materials

ISO/TC 194/WG 13, Toxicokinetics

ISO/TC 194/WG 14, Material characterization

ISO/TC 194/WG 16, Pyrogenicity

ISO/TC 194/WG 17, Nanomaterials

ISO/TC 194/WG 18, Attributes of medical devices relevant to biological risk assessment

ISO/TC 194/WG 19, Tissue product safety

ISO/TC 194/WG 2, Degradation aspects related to biological testing

ISO/TC 194/WG 3, Animal protection aspects

ISO/TC 194/WG 4, Clinical investigation and evaluation of medical devices in humans

ISO/TC 194/WG 5, Cytotoxicity

ISO/TC 194/WG 6, Mutagenicity, carcinogenicity and reproductive toxicity

ISO/TC 194/WG 7, Systemic toxicity

ISO/TC 194/WG 8, Irritation, sensitization

ISO/TC 194/WG 9, Effects on blood

SIS/TK 340/AG 03, Implantat:

CEN/CLC/JTC 16, Active Implantable Medical Devices

CEN/TC 285, Non-active surgical implants

ISO/TC 150, Implants for surgery

ISO/TC 150/SC 1, Materials

ISO/TC 150/SC 1/WG 3, Ceramics

ISO/TC 150/SC 1/WG 4, Metals

ISO/TC 150/SC 1/WG 5, Plastics

ISO/TC 150/SC 2, Cardiovascular implants and extracorporeal systems

ISO/TC 150/SC 2/WG 1, Cardiac valves

ISO/TC 150/SC 2/WG 3, Vascular prostheses

ISO/TC 150/SC 2/WG 4, Blood gas exchangers

ISO/TC 150/SC 2/WG 5, Renal replacement, detoxification and apheresis

ISO/TC 150/SC 2/WG 6, Vascular device-drug combination products

ISO/TC 150/SC 2/WG 7, Cardiovascular absorbable implants

ISO/TC 150/SC 4, Bone and joint replacements

ISO/TC 150/SC 4/WG 1, Mechanical testing

ISO/TC 150/SC 4/WG 3, Wear

ISO/TC 150/SC 4/WG 4, General requirements

ISO/TC 150/SC 6, Active implants

ISO/TC 150/SC 6/JWG 1, Joint ISO/TC 150/SC 6 - IEC/SC 62D WG: Cardiac pacemakers and implantable defibrillators

ISO/TC 150/SC 6/JWG 2, JWG between ISO/TC 150/SC 6 and IEC/SC62B: Effects of magnetic resonance imaging on active implantable medical devices

ISO/TC 150/SC 6/WG 3, Cochlear implants

ISO/TC 150/SC 7, Tissue-engineered medical products

ISO/TC 150/SC 7/WG 1, Management of risk

ISO/TC 150/SC 7/WG 3, Tissue-engineered medical products for skeletal tissues

ISO/TC 150/WG 10, Use and retrieval of surgical implants

ISO/TC 150/WG 12, Implant coatings

ISO/TC 150/WG 7, Fundamental standards

Show more Show less

Subjects

Health care technology (11) Biological evaluation of medical devices (11.100.20)


För dig som är kommittédeltagare

Klicka här för att ta dig till kommitténs digitala arbetsyta och röstningsportal.

Kommittén bidrar bland annat till de här tre målen: 

sdg3.png
sdg9.png
sdg10.png

Läs mer om de globala målen här >

Följ oss på vår LinkedIn, Hälsa, vård och omsorg SIS

Contact

If you have questions or want to know more about the SIS standardization activities? Please contact us.

Jenny Aromaa
Project manager
jenny.aromaa@sis.se

Mattis Rundgren
Project coordinator
mattis.rundgren@sis.se

Lars Magnus Bjursten
Chairman
Region Skåne